Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Human Genetics

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Incomplete Dominance

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.

Adrenergic Receptors: β Subtype

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Selective octopaminergic tuning of mushroom body circuits during memory formation.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Genetic dissection of serum pro-neurotensin suggests potential causal impact on brain structure.

EBioMedicine·2026

Same author

Inhibition of adipocyte lipolysis by vaspin impairs thermoregulation in vivo.

Nature communications·2025

Same author

Proenkephalin predicts kidney function and major adverse kidney events in CKD.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025

Same author

Genetic dissection of serum vaspin highlights its causal role in lipid metabolism.

Obesity (Silver Spring, Md.)·2023

Same author

Association between TGFβ1 Levels in Cord Blood and Weight Progress in the First Year of Life.

Biomedicines·2023

Search research articles

Related Experiment Video

Updated: May 23, 2026

Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting

Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting

Published on: March 17, 2023

Genetics of adiponectin.

Jana Breitfeld¹, Michael Stumvoll, Peter Kovacs

¹Department of Medicine, University of Leipzig, D-04103 Leipzig, Germany.

|March 28, 2012

Summary

Adiponectin, an adipokine with anti-inflammatory and anti-diabetic effects, is a key target in metabolism research. Genetic variations influence its levels and are linked to metabolic diseases like type 2 diabetes.

Area of Science:

Metabolic research
Genetics
Adipokine function

Background:

Adiponectin exhibits anti-inflammatory, anti-atherogenic, and anti-diabetic properties.
Genetic variations in adiponectin may influence metabolic disorder pathophysiology.
Understanding adiponectin genetics is crucial for metabolism research.

Purpose of the Study:

To summarize adiponectin genetics, focusing on gene structure and variation.
To review genetic studies identifying determinants of serum adiponectin levels.
To explore the role of genetic variants in metabolic disease pathophysiology.

Main Methods:

Review of genetic studies, including genome-wide linkage and association studies.
Analysis of gene structure and genetic variation in adiponectin.

More Related Videos

Expansion and Adipogenesis Induction of Adipocyte Progenitors from Perivascular Adipose Tissue Isolated by Magnetic Activated Cell Sorting

Expansion and Adipogenesis Induction of Adipocyte Progenitors from Perivascular Adipose Tissue Isolated by Magnetic Activated Cell Sorting

Published on: June 30, 2017

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro

Published on: December 5, 2025

Related Experiment Videos

Last Updated: May 23, 2026

Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting

Adipocyte-Specific ATAC-Seq with Adipose Tissues Using Fluorescence-Activated Nucleus Sorting

Published on: March 17, 2023

Expansion and Adipogenesis Induction of Adipocyte Progenitors from Perivascular Adipose Tissue Isolated by Magnetic Activated Cell Sorting

Expansion and Adipogenesis Induction of Adipocyte Progenitors from Perivascular Adipose Tissue Isolated by Magnetic Activated Cell Sorting

Published on: June 30, 2017

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro

Published on: December 5, 2025

Identification of genes and loci associated with circulating adiponectin levels.

Main Results:

Genome-wide studies identified major genetic determinants of serum adiponectin.
Variants in adiponectin gene and other loci (ARL15, CDH13, KNG1, FER, ETV5) affect adiponectin levels.
These variants are associated with metabolic phenotypes like obesity and type 2 diabetes.

Conclusions:

Genetic variations significantly contribute to circulating adiponectin levels.
Adiponectin's protective role in diseases like type 2 diabetes is supported by genetic findings.
Further analysis of adiponectin genetic variants can elucidate its role in metabolic diseases.